Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

B. Vander Cruyssen; R. Westhovens; P. Durez; F. Van Den Bosch; H. Mielants; L. De Clerck; A. Peretz; M. Malaise; Leon Verbruggen; L. Dewulf; N. Vastesaeger; A. Geldhof; W. Noel; L. Boullart; F. De Keyser

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

B. Vander Cruyssen, R. Westhovens, P. Durez, F. Van Den Bosch, H. Mielants, L. De Clerck, A. Peretz, M. Malaise, Leon Verbruggen, L. Dewulf, N. Vastesaeger, A. Geldhof, W. Noel, L. Boullart, F. De Keyser

Internal Medicine Specializations

Research output: Contribution to journal › Editorial

Abstract

No abstract available

Original language	English
Pages (from-to)	52-52
Number of pages	1
Journal	Scandinavian Journal of Rheumatology
Volume	37
Publication status	Published - 2008

Keywords

RA population
Rheumatology
survival

Access to Document

http://apps.webofknowledge.com.ezproxy.vub.ac.be:2048/full_record.do?product=UA&search_mode=GeneralSearch&qid=3&SID=Q26EJnA3F87EFGLBnDN&page=1&doc=2

Cite this

Vander Cruyssen, B., Westhovens, R., Durez, P., Van Den Bosch, F., Mielants, H., De Clerck, L., Peretz, A., Malaise, M., Verbruggen, L., Dewulf, L., Vastesaeger, N., Geldhof, A., Noel, W., Boullart, L., & De Keyser, F. (2008). Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population. Scandinavian Journal of Rheumatology, 37, 52-52. http://apps.webofknowledge.com.ezproxy.vub.ac.be:2048/full_record.do?product=UA&search_mode=GeneralSearch&qid=3&SID=Q26EJnA3F87EFGLBnDN&page=1&doc=2

Vander Cruyssen, B. ; Westhovens, R. ; Durez, P. ; Van Den Bosch, F. ; Mielants, H. ; De Clerck, L. ; Peretz, A. ; Malaise, M. ; Verbruggen, Leon ; Dewulf, L. ; Vastesaeger, N. ; Geldhof, A. ; Noel, W. ; Boullart, L. ; De Keyser, F. / Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population. In: Scandinavian Journal of Rheumatology. 2008 ; Vol. 37. pp. 52-52.

@article{b31d452f227f40eb823dce09434e2fb4,

title = "Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population",

abstract = "No abstract available",

keywords = "RA population, Rheumatology, survival",

author = "{Vander Cruyssen}, B. and R. Westhovens and P. Durez and {Van Den Bosch}, F. and H. Mielants and {De Clerck}, L. and A. Peretz and M. Malaise and Leon Verbruggen and L. Dewulf and N. Vastesaeger and A. Geldhof and W. Noel and L. Boullart and {De Keyser}, F.",

year = "2008",

language = "English",

volume = "37",

pages = "52--52",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Informa Healthcare",

}

Vander Cruyssen, B, Westhovens, R, Durez, P, Van Den Bosch, F, Mielants, H, De Clerck, L, Peretz, A, Malaise, M, Verbruggen, L, Dewulf, L, Vastesaeger, N, Geldhof, A, Noel, W, Boullart, L & De Keyser, F 2008, 'Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population', Scandinavian Journal of Rheumatology, vol. 37, pp. 52-52. <http://apps.webofknowledge.com.ezproxy.vub.ac.be:2048/full_record.do?product=UA&search_mode=GeneralSearch&qid=3&SID=Q26EJnA3F87EFGLBnDN&page=1&doc=2>

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population. / Vander Cruyssen, B.; Westhovens, R.; Durez, P.; Van Den Bosch, F.; Mielants, H.; De Clerck, L.; Peretz, A.; Malaise, M.; Verbruggen, Leon; Dewulf, L.; Vastesaeger, N.; Geldhof, A.; Noel, W.; Boullart, L.; De Keyser, F.

In: Scandinavian Journal of Rheumatology, Vol. 37, 2008, p. 52-52.

Research output: Contribution to journal › Editorial

TY - JOUR

T1 - Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

AU - Vander Cruyssen, B.

AU - Westhovens, R.

AU - Durez, P.

AU - Van Den Bosch, F.

AU - Mielants, H.

AU - De Clerck, L.

AU - Peretz, A.

AU - Malaise, M.

AU - Verbruggen, Leon

AU - Dewulf, L.

AU - Vastesaeger, N.

AU - Geldhof, A.

AU - Noel, W.

AU - Boullart, L.

AU - De Keyser, F.

PY - 2008

Y1 - 2008

N2 - No abstract available

AB - No abstract available

KW - RA population

KW - Rheumatology

KW - survival

M3 - Editorial

VL - 37

SP - 52

EP - 52

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

ER -

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

Abstract

Keywords

Access to Document

Fingerprint

Cite this